Pilot hip arthroscopy test

RNS Number : 6192G
Surgical Innovations Group PLC
10 June 2013




Surgical Innovations Group plc

("SI" or the "Company")


Pilot hip arthroscopy test


Surgical Innovations Group plc (AIM: SUN), the designer and manufacturer of creative solutions for minimally invasive surgery ('MIS'), announces that pilot testing for its prototype port access products for hip arthroscopy on a cadaver has concluded successfully.


The pilot testing for hip arthroscopy took place in Oxford and was overseen by one of SI's hip arthroscopy CAB members. Both the Company and the CAB member were pleased with the promising results produced from the test. The Company will continue to develop, modify and improve the port access system now the core functionalities have been demonstrated. SI intends to run a second cadaver with a wider group of surgeons to test refined pre-production prototypes.


SI plans to attend the International Society for Hip Arthroscopy ('ISHA') taking place in Munich in October 2013. It will give the Company the opportunity to meet surgeons with a common interest in the new technique and technology developed by SI for hip arthroscopic surgery.


Graham Bowland, Chief Executive Officer for Surgical Innovations, said: "I am pleased to announce that the Company's first pilot test for hip arthroscopy was such a success. With hip arthroscopy believed to be the fastest growing area within orthopaedic surgery SI is positioning itself to service the increasing demand for the required high quality, cost-effective instrumentation."




- ENDS -




Surgical Innovations Group plc


Doug Liversidge, Non-Executive Chairman

Tel: +44 (0) 113 230 7597

Graham Bowland, Chief Executive Officer




Panmure Gordon (Nominated Advisor & Broker)


Freddy Crossley / Fred Walsh (Corporate Finance)

Tel: +44 (0) 20 7886 2500

Adam Pollock/ Victoria Boxall (Corporate Broking)




Walbrook PR Ltd

Tel: +44 (0) 20 7933 8780 or si@walbrookpr.com

Paul McManus

Mob: 07980 541 893

Lianne Cawthorne

Mob: 07584 391 303


Notes to Editors:


About Surgical Innovations Group plc


Surgical Innovations Group plc specialises in the design and manufacture of creative solutions for minimally invasive surgery (MIS) and industrial markets. 


As well as manufacturing single-use and reusable instruments for the laparoscopic market, the Group has pioneered its flagship Resposable® instrumentation combining both single use and reusable components, ensuring ongoing revenue streams and delivering the optimum procedure performance to cost ratio.


Over 100 people are employed at the Group's 32,000 square feet facility in Leeds, with in-house design, plastic injection moulding and manufacturing equipment, producing products to the highest quality standards.


The Group's patented products are sold through three main channels:


SI brand

Through an established network of distribution partners, Surgical Innovations branded products are sold in major medical markets including North America, Britain, South East Asia, Australasia and the Indian subcontinent. 


OEM and IP

The Group supplies large medical device companies on an OEM basis, generating both sales and IP royalty fees.  Clients include Teleflex Medical, Olympus and CareFusion. 




SI's patented segment technology has been applied to the industrial market enabling customers to undertake inspection and maintenance of large-scale equipment, in situ with minimum disassembly and downtime. 


For more information, see www.sigrouplplc.com


This information is provided by RNS
The company news service from the London Stock Exchange
UK 100